Dr Hayden Bell Dr Helen Blair Samantha Jepson Gosling Dr Martin Galler Dan Astley et al. | Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia | 2024 |
|
Dr Dino Masic Dr Hayden Bell Dr Frederik van Delft Professor Julie Irving
| Selection of dormant cells during treatment of T-lineage lymphoblastic leukemia and CREB as a therapeutic target | 2024 |
|
Dr Frederik van Delft
| Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma | 2024 |
|
Dr Dino Masic Kayleigh Fee Dr Hayden Bell Marian Case Juan Ojeda Garcia et al. | Hyperactive CREB subpopulations increase during therapy in pediatric B-lineage acute lymphoblastic leukemia | 2023 |
|
Dr Simon Bomken Dr Amir Enshaei Dr Ed Schwalbe Dr Aneta Mikulasova Dr Masood Zaka et al. | Molecular characterisation and clinical outcome of B-cell precursor acute lymphoblastic leukaemia with IG-MYC rearrangement | 2023 |
|
Dr Hayden Bell Dr Helen Blair Mankaran Singh Professor Anthony Moorman Professor Olaf Heidenreich et al. | Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia | 2023 |
|
Dr Frederik van Delft Professor Simon Bailey Professor Roderick Skinner Dr Geoff Shenton Dr Peter Carey et al. | Unusual relapse of low hypodiploid acute lymphoblastic leukaemia in a family with Li-Fraumeni syndrome | 2023 |
|
Dr Frederik van Delft Dr Stephen Owens Dr Michael McKean Dr Yusri Taha Professor Sophie Hambleton et al. | Case report: severe acute pulmonary COVID-19 in a teenager post autologous hematopoietic stem cell transplant | 2022 |
|
Yuzhe Shi Melanie Beckett Dr Helen Blair Dr Ricky Tirtakusuma Dr Sirintra Nakjang et al. | Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia | 2021 |
|
Dr Frederik van Delft
| RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia | 2021 |
|
Dr Amir Enshaei Dr Sirintra Nakjang Lynne Minto Professor Julie Irving Beth Poole et al. | The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia | 2021 |
|
Professor Anthony Moorman Claire Schwab Emily Winterman Dr Frederik van Delft Professor Christine Harrison FRCPath FMedSci et al. | Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion | 2020 |
|
Marian Case Dr Dino Masic Dr David Jamieson Dr Frederik van Delft Professor Andrew Filby et al. | Label-Free Leukemia Monitoring by Computer Vision | 2020 |
|
Dr Nikoletta Panagiotopoulou Dr Frederik van Delft Dr Jane Stewart
| Fertility preservation knowledge, attitudes and intentions among children by proxy and adolescents with cancer | 2019 |
|
Dr Frederik van Delft Hany Gabra
| The peripheral portacath provides safe and convenient venous access in pediatric and adolescent patients | 2019 |
|
Dr Luca Ermini Dr Frederik van Delft Dr Sarah Jenkinson Professor Christine Harrison FRCPath FMedSci
| The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia | 2018 |
|
Dr Kate Musgrave Dr Frederik van Delft Dr Peter Avery Dr Tina Biss
| Cerebral sinovenous thrombosis in children and young adults with acute lymphoblastic leukaemia – a cohort study from the United Kingdom | 2017 |
|
Dr Nikoletta Panagiotopoulou Dr Frederik van Delft Dr Juliet Hale Dr Jane Stewart
| Fertility Preservation Care for Children and Adolescents with Cancer: An Inquiry to Quantify Professionals' Barriers | 2017 |
|
Dr Victoria Forster Dr Frederik van Delft Professor Roderick Skinner
| Reply: Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect | 2017 |
|
Dr Frederik van Delft Professor Roderick Skinner
| Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients | 2016 |
|
Dr Frederik van Delft
| Clonal origins of ETV6-RUNX1+ acute lymphoblastic leukemia: studies in monozygotic twins | 2015 |
|
Dr Frederik van Delft
| Disease evolution and outcomes in familial AML with germline CEBPA mutations | 2015 |
|
Dr Frederik van Delft
| Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia | 2015 |
|
Dr Frederik van Delft
| Genetic and Functional Diversity of Propagating Cells in Glioblastoma | 2015 |
|
Dr Frederik van Delft
| Protracted dormancy of pre-leukemic stem cells | 2015 |
|
Dr Frederik van Delft
| CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage | 2014 |
|
Dr Kate Musgrave Dr Frederik van Delft Dr Tina Biss
| Cerebral Venous Thrombosis As a Complication of Treatment for Acute Lymphoblastic Leukaemia in Children and Young Adults | 2014 |
|
Dr Frederik van Delft
| IDENTIFYING THE DEVELOPMENTAL LEVEL OF LEUKEMIA INITIATION IN ETV6-RUNX1+ACUTE LYMPHOBLASTIC LEUKEMIA BY STUDYING MONOZYGOTIC TWINS | 2014 |
|
Dr Frederik van Delft
| RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia | 2014 |
|
Dr Frederik van Delft Professor Christine Harrison FRCPath FMedSci
| The Sub-Clonal Complexity of STIL-TAL1 T-ALL | 2014 |
|
Dr Frederik van Delft Professor Olaf Heidenreich Professor Bryan Young
| AML1/ETO and POU4F1 synergy drives B-lymphoid gene expression typical of t(8;21) acute myeloid leukemia | 2012 |
|
Dr Frederik van Delft
| Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia | 2011 |
|
Dr Frederik van Delft
| Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukaemia | 2011 |
|
Dr Frederik van Delft Professor Anthony Moorman
| Genetic variegation of clonal architecture and propagating cells in leukaemia | 2011 |
|
Dr Frederik van Delft
| Modeling the evolution of ETV6-RUNX1-induced B-cell precursor acute lymphoblastic leukemia in mice | 2011 |
|
Dr Frederik van Delft
| Occurrence of identical NOTCH1 mutation in non-twinned sisters with T-cell acute lymphoblastic leukemia | 2011 |
|
Dr Frederik van Delft Professor Anthony Moorman Professor Christine Harrison FRCPath FMedSci
| Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization | 2007 |
|
Dr Frederik van Delft Professor Christine Harrison FRCPath FMedSci
| Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 | 2006 |
|
Dr Frederik van Delft
| Qualified predictions for microarray and proteomics pattern diagnostics with confidence machines | 2005 |
|